PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
KRYS vs. COOP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

KRYS vs. COOP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Krystal Biotech, Inc. (KRYS) and Mr. Cooper Group Inc. (COOP). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
5.23%
16.36%
KRYS
COOP

Returns By Period

In the year-to-date period, KRYS achieves a 43.56% return, which is significantly lower than COOP's 49.09% return.


KRYS

YTD

43.56%

1M

-0.49%

6M

5.23%

1Y

75.90%

5Y (annualized)

26.85%

10Y (annualized)

N/A

COOP

YTD

49.09%

1M

5.64%

6M

16.36%

1Y

61.82%

5Y (annualized)

49.65%

10Y (annualized)

16.65%

Fundamentals


KRYSCOOP
Market Cap$5.12B$6.21B
EPS$1.78$7.78
PE Ratio99.9212.48
Total Revenue (TTM)$241.52M$2.12B
Gross Profit (TTM)$220.04M$933.00M
EBITDA (TTM)$63.99M$736.00M

Key characteristics


KRYSCOOP
Sharpe Ratio1.222.37
Sortino Ratio2.543.24
Omega Ratio1.291.39
Calmar Ratio3.055.20
Martin Ratio6.8815.82
Ulcer Index10.17%3.99%
Daily Std Dev57.49%26.57%
Max Drawdown-53.42%-87.08%
Current Drawdown-16.64%-4.28%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.2

The correlation between KRYS and COOP is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

KRYS vs. COOP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and Mr. Cooper Group Inc. (COOP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for KRYS, currently valued at 1.22, compared to the broader market-4.00-2.000.002.004.001.222.37
The chart of Sortino ratio for KRYS, currently valued at 2.54, compared to the broader market-4.00-2.000.002.004.002.543.24
The chart of Omega ratio for KRYS, currently valued at 1.29, compared to the broader market0.501.001.502.001.291.39
The chart of Calmar ratio for KRYS, currently valued at 3.05, compared to the broader market0.002.004.006.003.055.20
The chart of Martin ratio for KRYS, currently valued at 6.88, compared to the broader market-10.000.0010.0020.0030.006.8815.82
KRYS
COOP

The current KRYS Sharpe Ratio is 1.22, which is lower than the COOP Sharpe Ratio of 2.37. The chart below compares the historical Sharpe Ratios of KRYS and COOP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
1.22
2.37
KRYS
COOP

Dividends

KRYS vs. COOP - Dividend Comparison

Neither KRYS nor COOP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

KRYS vs. COOP - Drawdown Comparison

The maximum KRYS drawdown since its inception was -53.42%, smaller than the maximum COOP drawdown of -87.08%. Use the drawdown chart below to compare losses from any high point for KRYS and COOP. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-16.64%
-4.28%
KRYS
COOP

Volatility

KRYS vs. COOP - Volatility Comparison

Krystal Biotech, Inc. (KRYS) has a higher volatility of 13.41% compared to Mr. Cooper Group Inc. (COOP) at 9.88%. This indicates that KRYS's price experiences larger fluctuations and is considered to be riskier than COOP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JuneJulyAugustSeptemberOctoberNovember
13.41%
9.88%
KRYS
COOP

Financials

KRYS vs. COOP - Financials Comparison

This section allows you to compare key financial metrics between Krystal Biotech, Inc. and Mr. Cooper Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items